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Abstract
A replenishable source of insulin-producing cells has the potential to cure type 1 diabetes.
Attempts to culture and expand pancreatic β-cells in vitro have resulted in their transition
from insulin-producing epithelial cells to mesenchymal stromal cells (MSCs) with high prolif-
erative capacity but devoid of any hormone production. The aim of this study was to deter-
mine whether the transcription factor Krüppel-like factor 4 (KLF4), could induce a
mesenchymal-to-epithelial transition (MET) of the cultured cells. Islet-enriched pancreatic
cells, allowed to dedifferentiate and expand in adherent cell culture, were transduced with
an adenovirus containing KLF4 (Ad-Klf4). Cells were subsequently analysed for changes in
cell morphology by light microscopy, and for the presence of epithelial and pancreatic mark-
ers by immunocytochemistry and quantitative RT/PCR. Infection with Ad-Klf4 resulted in
morphological changes, down-regulation of mesenchymal markers, and re-expression of
both epithelial and pancreatic cell markers including insulin and transcription factors specific
to β-cells. This effect was further enhanced by culturing cells in suspension. However, the
effects of Ad-KLf4 were transient and this was shown to be due to increased apoptosis in
Klf4-expressing cells. Klf4 has been recently identified as a pioneer factor with the ability to
modulate the structure of chromatin and enhance reprogramming/transdifferentiation. Our
results show that Klf4 may have a role in the redifferentiation of expanded pancreatic cells
in culture, but before this can be achieved the off-target effects that result in increased apo-
ptosis would need to be overcome.
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Introduction
Transplantation of islets holds great promise as a cure for type 1 diabetes. The introduction of
the Edmonton protocol in 2000 demonstrated that human donor islet transplantation can lead
to a significant decrease in exogenous insulin requirements and even temporary insulin inde-
pendence along with reduction of severe hypoglycaemia [1]. Islet cell transplantation is limited
by the availability of donor tissue; therefore an alternative replenishable source of β-cells is
required. Using adult human β-cells as a starting population and expanding them in vitro
would seem like an obvious solution, but is one that has been met with little progress despite
considerable effort [2].
Isolated human islets of Langerhans can be maintained as functional units in suspension
culture for many months without proliferation [3,4]. However, when human islets are placed
in adherent culture conditions, fibroblast-like cells migrate out from the islet foci [5]. These
cells can proliferate and form a monolayer that can be grown to passage 20 and beyond. A sim-
ilar scenario occurs when the islets are dispersed and plated as single cells [6]. Formation of the
fibroblast-like monolayer is accompanied by loss of epithelial markers, acquisition of mesen-
chymal markers and loss of hormone secretion from the islets including insulin and other hor-
mones. The fibroblast-like cells express cell surface markers (CD90, CD107 and CD73) of
mesenchymal stromal cells (MSC) and can, in keeping with the properties of MSCs, be induced
to redifferentiate towards osteoblast, chondrocyte and adipocyte lineages. There is some con-
troversy concerning the origins of the MSCs that occur when islets are placed in culture.
Genetic lineage tracing studies in mice showed that β-cells dedifferentiated in culture but failed
to proliferate and were eliminated from the culture [7–9]. However, genetically traced cultured
human β-cells dedifferentiate and replicate [6,10,11]. It is likely that the MSC population arises
from dedifferentiated epithelial cells via a process of EMT as well as from passenger stromal
cells.
If this process can be reversed, i.e. by inducing a mesenchymal-to-epithelial transition
(MET) there is potential to generate clinically meaningful numbers of β-cells [12]. Some prog-
ress has been made. Thus when human islet-derived MSCs are transferred from serum-con-
taining to serum-free medium, the cells form epithelial-like clusters and re-express low levels
of endocrine hormones [5,13]. This effect can be enhanced by addition of soluble factors or by
targeting components of the EMT signalling pathway [14–16].
It is of relevance that MET [17,18] may be an early and essential process in the generation
of induced pluripotent stem cells (iPSCs) from murine fibroblasts using the transcription factor
cocktail Oct4, Sox2, Klf4 and c-Myc [19]. Krüppel-like factor 4 (KLF4), a multi-zinc finger
SP1-like transcription factor, appears fundamental to this process, as when overexpressed in
the absence of the other transcription factors, epithelial markers were up-regulated signifi-
cantly [18]. Furthermore, KLF4 was shown to bind to the E-cadherin promoter [20,21] and to
act as a transcriptional repressor of genes critical for EMT, including SLUG and JNK1 [22].
We hypothesised that KLF4 may also play a similar role in promoting a MET in dedifferen-
tiated pancreatic cells, and if these cells retained epigenetic memory of their origins, as sug-
gested by other studies, it would allow preferential lineage-specific differentiation. If feasible,
this strategy would have the potential to produce a replenishable supply of β-cells through tar-
geting pathways required for MET, whilst bypassing pluripotency and its associated risks. Here
we demonstrate that KLF4 can initiate a transient MET in MSCs derived from islet-enriched
pancreatic cells, as evidenced by up-regulation of epithelial markers and down-regulation of
mesenchymal markers. However, KLF4 also promoted cell death via apoptosis. This suggests
that before transcription factor mediated reversal of MET can play a role in cell therapy these
off- target effects of KLF4 would need to be addressed.
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Materials and Methods
Culture of human islet- enriched pancreatic fractions
All human tissue was procured with written informed consent from the donor or next of kin
and with ethical approval from the North of Scotland Research Ethics Committee (REC refer-
ence number 10/S0802/12). Human islets were isolated from brain-dead adult donor pancreata
at the Scottish Islet Isolation Laboratory, Edinburgh, UK, under GMP conditions. Islet-
enriched fractions were plated at a density of 3 x 105 clusters on 75 cm2 tissue culture flasks
(Greiner, Stonehouse, UK) and cultured in serum-containing medium (SCM) prepared using
RPMI 1640 (Gibco, Life Technologies, Paisley, UK) supplemented with 10% FBS, 10 mM
HEPES, 1 mM sodium pyruvate (all from Gibco), and 75 μM β-mercaptoethanol (Sigma
Aldrich, Dorset, UK). Cells were passaged every 5–7 days using trypsin (0.05%) and EDTA
(0.02%, Gibco). Serum-free medium (SFM) was prepared with RPMI supplemented with 1%
BSA and 10 μg/ml insulin, 5.5 μg/ml transferrin and 6.7 ng/ml sodium selenite.
Viral vectors
Adenoviral vectors pAd-Klf4 and pAd-EGFP were obtained from Addgene. Adenoviral-medi-
ated transduction was performed in SFM at a multiplicity of infection of 25. Reprogramming
using Ad-Pdx1, Ad-MafA, Ad-Ngn3 and Ad-Pax4 (4TFs) was as previously described [11].
Genetic Lineage Tracing
Genetic lineage tracing was performed as previously described [11].
Fluorescence activated cell sorting
Cells for sorting were incubated in StemPro1 Accutase1 (Life Technologies, Paisley UK) for
10 min followed by pipetting to break up clusters. Cells were then passed through a 70 μm cell
strainer and dsRed positive cells sorted on a BD InfluxTM Cell Sorter using a phycoerythrin
593/40 filter. Collected dsRed- positive cell fractions were then expanded in adherent culture
for a further 8 weeks prior to further experiments.
Differentiation towards adipocyte and osteocyte lineages
Islet-derived dsRed sorted cells were seeded at a density of 2x104 cells on 22x22 mm coverslips.
The cells were cultured in the presence of StemPro Osteogenesis differentiation medium (Life
Technologies) for 20 days or StemPro Adipogenesis medium (Life Technologies) for 10 days.
Quantitative RT/PCR
Quantitative RT-PCR was performed as previously described [11]. Samples were run in tripli-
cate and normalised to glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Data were ana-
lysed using the 2–ΔΔCT method. Statistical analysis was performed using GraphPad Prism
software and the Student t test or one-way/two-way ANOVA, followed by the Dunnett post
hoc test, were used as appropriate. TaqMan primers sequences are shown in Table 1.
Immunocytochemistry
Cells were cultured on 22 x 22 mm or 13 mm round glass coverslips. Immunocytochemistry
was performed as previously described [11,23]. Fluorescent Images were captured using a Zeiss
Axio Imager.M2 and collated with AxioVision software. Antibodies used are shown in Table 2.
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TUNEL assay
Cells were seeded on 22x22 mm coverslips and after 24 h infected with Ad-KLF4. The anti-pro-
liferative agent, paclitaxel was used as a positive control to induce apoptosis. A terminal deoxy-
nucleotidyl transferase mediated dUTP nick-end labelling (TUNEL) assay was performed
using the ApopTag Fluorescein Direct In Situ Apoptosis Detection kit (Millipore, Watford,
UK) according to the manufacturer’s instructions. Cell counts were performed over 10 ran-
domly selected fields over 2 slides with at least 700 nuclei per slide. TUNEL positive cells were
identified using the FITC channel on a Zeiss Axio Imager.M2 fluorescence microscope.
Results
Freshly isolated islet-enriched pancreatic cells undergo EMT in adherent
cell culture
When plated in plastic tissue culture dishes the islet clusters attached to the dish. Within 24 h
fibroblast-like cells started to migrate out of the cluster, forming a proliferative monolayer that
spread throughout the culture dish (Fig 1A). This monolayer could be repeatedly passaged. At
passage 6 (approximately 4 weeks), the cell population resembled a monolayer of mesenchymal
stromal cells (Fig 1A). In keeping with previous studies [5,24] there was a rapid decrease in
expression of epithelial markers (insulin, glucagon, somatostatin, PDX1, E-cadherin and Ep-
cam with a concomitant increase in expression of the mesenchymal markers vimentin and
SNAI2 (SLUG) (Fig 1B). We have previously shown that these fibroblast-like cells express sur-
face antigens that are characteristic of mesenchymal stromal cells (MSCs), and in keeping with
the properties of MSCs can be differentiated into adipocytes, osteoblasts and chondrocytes
[11]. A weak expression (relative to ES cells) of pluripotency markers (OCT4, SOX2 and
NANOG) was detected in the newly plated islets; however this was rapidly lost, and there was
no transient increase around passage 5 (Fig 1C) as reported by others [25]. We have shown
previously [11] that these MSC-like cells arise from dedifferentiation via a process of epithelial
Table 1. List of Taqman1 gene expression primers.
Gene Assay Identiﬁcation
CDH1 Hs01023894_m1
EPCAM Hs00901885_m1
VIM Hs00185584_m1
SNAI2 Hs00950344_m1
ZEB1 Hs00232783_m1
ACTA2 Hs00909449_m1
GAPDH Hs99999905_m1
RPL13A Hs04194366_g1
INS Hs00355773_m1
GCG Hs00174967_m1
SST Hs001174949_m1
AMY2B Hs00949916_m1
KRT19 Hs00761767_s1
PDX1 Hs00236830_m1
OCT4 Hs04260367_gH
SOX2 Hs01053049_s1
NANOG Hs04260366_g1
KLF4 (mouse) Mm00516105_g1
doi:10.1371/journal.pone.0140352.t001
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to mesenchymal transition of pancreatic endocrine and exocrine cells as well as from expansion
of endogenous stromal cells.
Klf-4 overexpression induces a MET and redifferentiation towards
pancreatic cell types
There was no detectable endogenous KLF4 in untreated cells (Fig 2A). Ad-Klf4 was efficiently
taken up by 71.3% ± 15.1% of the islet- derived MSCs (Fig 2A) with rapid expression of the
exogenous mouse Klf4 peaking at day 2, followed by a subsequent fall to undetectable levels by
day 8 (Fig 2B). Following Ad-Klf4 transduction, the islet-derived MSCs underwent significant
morphological changes with aggregation and many cells transitioning towards a more rounded
epithelial form (Fig 2C). This was not seen in Ad-EGF treated control cells. In Ad-Klf4, but not
Table 2. Primary antibodies used in immunofluorescence.
Antigen Antibody host Source Dilution used
E Cadherin Mouse Becton Dickinson 1:200
Vimentin Rabbit Dako 1:200
Vimentin Mouse Proteintech 1:200
Amylase Rabbit Sigma 1:100
KLF4 Rabbit Millipore 1:300
C-peptide Mouse Cell Signalling 1:1000
Cleaved Caspase-3 Rabbit NE biolabs 1:200
Osteocalcin Mouse Abcam 1:50
doi:10.1371/journal.pone.0140352.t002
Fig 1. Islet enriched pancreatic cells form fibroblast-like monolayers and dedifferentiate in adherent
cell culture. A: Phase contrast images taken in culture from day 0 to passage 6. QRT/PCR analysis of
endocrine, epithelial, mesenchymal (B) and pluripotency markers (C) in cells harvested from passage 1 to
passage 9 in tissue culture. Data are expressed relative to glyceraldehyde 3-phosphate dehydrogenase.
ESC are human embryonic stem cells.
doi:10.1371/journal.pone.0140352.g001
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Ad-EGFP, treated cells expression of the epithelial markers E-cadherin (ECAD) and epithelial
cell adhesion molecule (Ep-CAM) was rapidly up-regulated to significant levels peaking at day
4, with a subsequent decrease towards day 6 (Fig 2D). Widespread E-cadherin staining was
detected (38.3% ± 5.5%) in Ad-Klf4 treated cells, but not in Ad-EGFP, transduced cells, with
positive cells displaying a more epithelial morphology (Fig 2E). Conversely, expression of the
mesenchymal markers α-SMA, and the transcriptional repressor SNAI2 was down-regulated
significantly at day 2 after transduction, but increased towards baseline levels upon further cul-
ture (Fig 2D). This was accompanied by perinuclear relocation of vimentin in cells staining
positive for E-cadherin (Fig 2E).
In addition to the up-regulation of epithelial markers, Klf4 overexpression led to a signifi-
cant transient increase in the expression of the endocrine hormones insulin and somatostatin
(Fig 3A) and pancreatic transcription factors (PDX1, NGN3, NKX6.1 and MAFA) that are
Fig 2. KLF4 overexpression inducesmorphological change with up-regulation of epithelial markers and down-regulation of mesenchymal
markers. Islet enriched pancreatic cell clusters were cultured in RPMI with 10% FBS and allowed to adhere and expand. (A) At passage 6 cells were
transduced with Ad-Klf4. The left panel shows untreated cells (NA) and the right panel cells treated with Ad-KLf4. Cells were stained with DAPI (nuclei) and
anti-KLF4 (green). (B) QRT/PCR analysis of exogenous (mouse) Klf4 expression up to day 10 in transduced (klf4) and untreated (NA) cells. The dotted line
represents the time of adenoviral transduction. Data are expressed relative to glyceraldehyde 3-phosphate dehydrogenase and represent mean ± SEM
(n = 3). (C) Phase-contrast images showing morphological changes at time points post infection with Ad-Klf4 or Ad-EGFP. (D) Cells were harvested at time
points for gene expression by QRT/PCR. Data were expressed relative to glyceraldehyde-3-phosphate dehydrogenase (n = 3). A two-way ANOVA was
performed with Bonferroni post hoc test comparing treatment groups with Ad-EGFP. For all analyses, *P < 0.05 **P < 0.01 ***P < 0.001. (E)
Immunocytochemical staining of the epithelial marker E-cadherin and the mesenchymal marker vimentin at day 4 post transduction with Ad-Klf4 versus
control. Nuclei were counterstained with DAPI. Scale bar = 20μm.
doi:10.1371/journal.pone.0140352.g002
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Fig 3. KLF4 overexpression induces re-expression of both endocrine and exocrinemarkers. Islet enriched pancreatic cell clusters were cultured in
RPMI with 10% FBS and allowed to adhere and expand. At passage 6 cells were transduced with Ad-Klf4 or Ad-EGFP. (A) QRT/PCR analysis of pancreatic
markers in transduced cells. The dotted line represents the time of adenoviral transduction. Data represent mean ± SEM (n = 3) (B) QRT/PCR analysis of
insulin (INS) and glucagon (GCG) expression in cells transduced with Ad-Klf4 or Ad-Klf4 in combination with Ad-Pdx1, Ad-Ngn3, Ad-MafA and Ad-Pax4
(4TFs). Data are expressed relative to glyceraldehyde 3-phosphate dehydrogenase and expressed as mean ± SEM (n = 3). Samples transduced with Ad-
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present in developing and mature β-cells (Fig 3A). Expression levels of the acinar marker amy-
lase and ductal marker CK19 were also significantly increased (Fig 3B). Interestingly, there was
no increase in expression of glucagon (Fig 3A). We have previously shown [11] that repro-
gramming of pancreatic MSC-like cells using Ad-Pdx1, Ad-MafA, Ad-Ngn3 and Ad-Pax4
(4TFs) generates functional glucagon expressing α-like cells with no detectable expression of
insulin (Fig 3B). Suppression of EMT using TGFβ1 and Rho kinase inhibitors enhanced 4TF-
mediated insulin expression and suppressed glucagon expression [11]. In keeping with this
observation, a similar effect was observed when promoting MET with Ad-Klf4 in combination
with the 4TFs (Fig 3B). The effect on insulin expression was transient, suggesting that 4TFs
alone were unable to stabilise the transient effects of Klf4.
C-peptide positive cells were infrequently observed (10.4% ± 3.1%) by immunocytochemis-
try in Ad-Klf4 but not Ad-EGFP treated cells; however chromogranin A, a pan-endocrine
marker was seen throughout (32.1% ± 2.2%) following Ad-Klf4 treatment (Fig 3C). Immuno-
cytochemistry also revealed widespread staining for amylase (59.0% ± 12.13%) and CK19
(34.7% ± 5.6%) with many cells staining for both (Fig 3D). Similar co-expression of amylase
and CK19 was observed during the dedifferentiation of exocrine enriched cells [11,26].
We hypothesised that the transient nature of the Klf4 effect could be attributed in part to
the use of non-integrating adenoviral vectors. To address this we created a lentiviral vector
overexpressing human KLF4, which would integrate into the host genome. Lenti-KLF4, but
not Lenti-EGFP, induced an increase in E-cadherin, insulin, amylase and CK19, but not (as
seen with Ad-Klf4) glucagon expression. However, as seen with the Ad-Klf4 construct, the
increased expression of these markers was transient (Fig 4A). Collectively, these data suggest
that exogenous Klf4 is capable of initiating a process of MET but that other factors might be
required for further maturation and stabilisation of the epithelial phenotype. Some evidence in
favour of the requirement for these factors was provided by the observed co-staining of the
apoptotic marker CASP3 and E-cad in Ad-Klf4 infected cells (Fig 4B), while a TUNEL assay,
which measured a later stage apoptosis, revealed a significantly higher number of apoptotic
cells following treatment with Ad-Klf4 (Fig 4C).
Promoting cell-to-cell contact in suspension culture enhances KLF4
induced redifferentiation
We next hypothesised that adjusting the cell culture environment to promote survival of newly
formed epithelial cells would enhance redifferentiation. Initial experiments involved treatment
with Ad-Klf4 along with the Rho-associated kinase inhibitor (ROCK) Y27632, which has previ-
ously been effective in preventing apoptosis in dissociated pluripotent stem cells [27] and sup-
pressing pancreatic exocrine cell dedifferentiation [11]. However, no significant difference in
gene expression was observed between treatment groups (data not shown). We next investi-
gated whether coating the culture dish with different laminin isoforms, including those known
to interact with β-cells in the human basal lamina [28], would enhance Ad-Klf4-mediated
redifferentiation. Freshly-plated islet derived MSCs became fully attached to laminin isoforms
LN511 and LN521 after only 8 hours, while attachment to other isoforms and to glass took sig-
nificantly longer (a full 24 hours). Four days after Ad-Klf4 transduction, superior attachment
was observed on the LN521 coating, but not on the other isoforms. However, none of the
Klf4 or Ad-EGFP were immunostained at day 4 for E-cadherin, C-peptide and Chromogranin A (C) and for Amylase and CK19 (D). Nuclei were
counterstained with DAPI. Scale bar = 20μm.
doi:10.1371/journal.pone.0140352.g003
KLF4 Induces MET in Pancreatic MSCs
PLOSONE | DOI:10.1371/journal.pone.0140352 October 12, 2015 8 / 16
laminin isoforms enhanced Ad-Klf4 expression of insulin, amylase, CK19 and E-cadherin
(data not shown).
It has been previously shown that suspension culture in serum free media can enhance
redifferentiation of islet- and exocrine-derived MSCs [5,29]. Culture in suspension for 5 days
led to the formation of epithelial-like clusters (Fig 5A). In monolayer culture Ad-Klf4, but not
Ad-EGFP, increased expression of epithelial markers, and this effect was considerably
enhanced when the Ad-Klf4 treated cells were subsequently placed in suspension, under which
conditions a marked decrease in mesenchymal markers (vimentin and SNAI2) was also
observed (Fig 5B). However, the levels of the pancreatic markers insulin, amylase and Ngn3
decreased by day 6, with a concomitant increase in the mesenchymal markers α-SMA and
SLUG, indicating that the effect of Ad-Klf4 remained transient.
Fig 4. Effect of KLF4 is transient and induces apoptosis in treated cells. Islet-derived MSCs at passage 6 were transduced with lenti-KLF4 or lenti-EGFP
and harvested at time points. (A) QRT/PCR analysis for expression of the indicated genes following culture for the indicated days after transduction with
Lenti-Klf4 or Lenti-EGFP. The data are expressed relative to glyceraldehyde-3-phosphate dehydrogenase and represent the mean ± SEM (n = 3). A two-way
ANOVA was performed on all QRT/PCR analyses with Bonferroni post hoc test comparing treatment groups with lenti-GFP. For all analyses, P *< 0.05
**P < 0.01 ***P < 0.001. (B) Cleaved caspase 3 (CASP3) co-expresses with E-cadherin (ECAD) in Ad-Klf4 but not Ad-EGFP treated cells. Nuclei were
counterstained with DAPI. Scale bar = 20μm. (C) Cells were subjected to UV light or transduced with Ad-KLF4 or Ad-EGFP (NA) and fixed at day 4. A TUNEL
assay was performed followed by counterstaining with DAPI. Over 1500 nuclei were counted per treatment and cells identified as apoptotic calculated as a
percentage of all cells.
doi:10.1371/journal.pone.0140352.g004
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Fig 5. Suspension culture enhances the effects of Ad-Klf4. Islet-derived MSCs at passage 6 were transduced with Ad-Klf4 or Ad-EGFP and cultured
overnight in adherent cell culture conditions. The cells were then either left in adherent conditions or transferred to suspension culture for a further 4 days. (A)
Phase contrast comparison of cells in adherent or suspension culture at day 5. (B) Samples were harvested for QRT/PCR at several time points and
analysed for expression of pancreatic, epithelial and mesenchymal markers. Data were expressed relative to glyceraldehyde-3-phosphate dehydrogenase
and represent the mean ± SEM (n = 3). A one-way ANOVA was performed on all QRT/PCR analyses with Dunnett post hoc test comparing treatment groups
with an Ad-EGFP control. Unpaired t-tests were performed where necessary. For all analyses, P *< 0.05 **P < 0.01 ***P < 0.001.
doi:10.1371/journal.pone.0140352.g005
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β-cell derived MSCs redifferentiate down both endocrine and exocrine
lineages following treatment with Ad-KLF4
The question remained as to whether KLF4 was inducing a redifferentiation via MET of MSCs
derived from dedifferentiated islet cells or was acting exclusively on an expanded endogenous
stroma- derived population of MSCs. To investigate this we used a genetic lineage tracing
approach that we have previously described [11,26]. This involved using a lentivirus containing
Cre-recombinase under the control of the insulin promoter and a lentivirus containing a CMV
driven dsRed reporter preceded by a floxed stop cassette blocking its expression (Fig 6A). The
cells were allowed to dedifferentiate, and after several passages the dsRed positive cells were
sorted by flow cytometry and expanded to provide almost homogeneous (>94%) populations
of MSCs (Fig 6B) that were derived from insulin positive β-cells (INS-dsRed MSCs). We were
then able to demonstrate that MSCs derived from β-cells could be induced to differentiate
down adipocyte and osteoblast lineages (Fig 6C and 6D). When treated with Ad-Klf4 INS-
dsRed cells were shown to co-stain for dsREd and E-cadherin (14.6% ± 2.6%), chromogranin A
(14.3% ± 5.7%) and CK19 (6.7% ± 3.4%, Fig 7A), and by RT/QPCR to express E-cadherin,
insulin, somatostatin, CK19 and amylase (but not glucagon) (Fig 7B). These effects were not
seen with dsRed-enriched cells treated with Ad-EGFP. Collectively these results suggest that
Ad-KLF4 can transiently reverse EMT in MSCs derived from β-cells. Similar results were
obtained for AMY-dsRed MSCs [11], indicating that β-cell and acinar cell derived MSCs have
the ability to redifferentiate towards both endocrine and exocrine lineages after long term
culture.
Discussion
We have previously shown that human exocrine-enriched cells can be efficiently repro-
grammed into functional β-like cells, using a combination of four pancreatic transcription fac-
tors, namely Pdx1, MafA, Ngn3 and Pax4 [11]. Efficient reprogramming was dependent on
EMT suppression through a combination of TGFβ1 and Rho-kinase inhibitors. When the exo-
crine cells were allowed to expand as an MSC population the same protocol generated, for rea-
sons that are not completely understood, predominantly α-like cells. It was envisaged that the
β-cell directed reprogramming protocol would provide a recipient-specific supply of new β-
cells that could be used for subsequent transplants, since it often takes two and sometimes
three transplants to attain insulin dependence, and as a top-up supply of β-cells as the initial
graft deteriorated with time [30]. An alternative scenario, addressed here, was that a large sup-
ply of culture-expanded allogeneic MSCs from a single donor could be redifferentiated and
used to treat a large number of diabetic patients. The aim of this study was therefore to discover
mechanisms that would reverse the dedifferentiation process that pancreatic islet tissue under-
goes when placed in culture. There are very few proven strategies to induce MET in culture.
Because of its role in inducing MET during the generation of iPS cells, we hypothesised that
KLF4 might also act as an inducer of MET in MSCs expanded from human islets.
The major finding of the study was that adenovirus mediated overexpression of Klf4 in
MSCs derived from islet enriched pancreatic cells drives MET and redifferentiation towards
pancreatic cell types. Recent studies provide insights into how Klf4 might be acting in this pro-
cess [31]. Klf4 belongs to a family of pioneer transcription factors, which can bind to highly
condensed heterochromatin [32]. Through mechanisms that are not completely understood
binding of Klf4 allows the chromatin to “breathe” thus allowing binding of other transcription
factors to initiate gene transcription [33]. The three of the four transcription factors used in the
reprogramming of iPSCs, i.e. Oct4, Sox2 and Klf4 (OSK) are all pioneer factors [19]. In our
studies KLf4 was shown to reverse the EMT that pancreatic cells underwent in culture; however
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Fig 6. β-cell derived MSCs can be differentiated towards adipocyte and osteoblast lineages. (A) Islets
were transduced 24h after plating with a lenti virus encoding Cre recombinase under the control of the insulin
promoter (Le-INS-Cre) and a lentivirus encoding dsRED preceded by a floxed stop cassette (Le-dsRED).
These lineage traced beta cells were allowed to expand in culture for 6 weeks. (B) The expanded dsRed+
beta-derived MSCs were FACS sorted and cultured up to passage 4. Left panel dsRed, middle DAPI, and
right merged. (C) Immunostaining of sorted β-cell derived MSCs upon differentiation towards adipocytes (lipid
droplets, LipidTox) or osteoblasts (osteocalcin). Scale bar = 50μm. Quantification of the percentage of
differentiation towards adipocytes (D) and osteoblasts (E). >1500 nuclei were counted per treatment and
cells identified as positive calculated as a percentage of total cells.
doi:10.1371/journal.pone.0140352.g006
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Fig 7. Ad-Klf4 induces INS-dsRed MSCs to differentiate down both endocrine and exocrine lineages. (A) FACS sorted and expanded INS-dsRED
MSCs were transduced with Ad-Klf4, samples fixed for immunocytochemistry and stained for E-cadherin, chromogranin A and CK19. Nuclei were
counterstained with DAPI. Scale bar = 20μm. (B) FACS sorted and expanded INS-dsREDMSCs were transduced with Ad-Klf4 or Ad-EGFP. Samples were
harvested for QRT/PCR analysed for expression of epithelial and endocrine markers, relative to glyceraldehyde-3-phosphate dehydrogenase and
represented as mean ± SEM (n = 3). Unpaired t-tests were performed between Ad-Klf4 and Ad-EGFP transduced cells. For all analyses, P *< 0.05
**P < 0.01 ***P < 0.001.
doi:10.1371/journal.pone.0140352.g007
KLF4 Induces MET in Pancreatic MSCs
PLOSONE | DOI:10.1371/journal.pone.0140352 October 12, 2015 13 / 16
this was associated with increased apoptosis in Klf4- expressing cells. This suggests that Klf4
can make accessible not only sites within silent chromatin that control MET, but also addi-
tional sites, including those responsible for initiating an apoptotic cascade. Such a process may
also occur during the generation of iPSCs and in part explain the very low efficiency of iPSC
production.
Culture-expanded MSCs consist of a heterogeneous population of cells exhibiting a spec-
trum of phenotypes and functional properties [34]. The extent of this heterogeneity is depen-
dent on a number of variables including: the tissue, donor and species of origin, isolation
technique, culturing protocols, media used, and passage number [35,36]. We show here that
MSCs derived from insulin positive β-cells or amylase-positive acinar cells are functionally
equivalent, in that they can both be induced by Ad-Klf4 to express endocrine and exocrine
markers and have the feature common to all MSC populations of being able to differentiate
towards adipose and osteogenic lineages. This has important implications for cell therapy
approaches to the treatment of type 1 diabetes since dedifferentiation, expansion, and rediffer-
entiation of pancreatic tissue left over from the islet isolation procedure could provide a poten-
tially unlimited supply of islets for transplantation [2]. The current study demonstrates that
islet isolates that were not able to be utilised due to not meeting adequate numbers (<200, 000
islet equivalent units), as well as islet tissue left over from isolates that have been directed
towards transplantation, or indeed exocrine tissue, would be equally useful for this purpose.
Overall the results suggest that Klf4 may play a pivotal role in attempts to generate an
expandable source of islets for transplantation. However, further experiments should focus on
minimising the off-target effects of Klf4 that result in apoptosis. This could be achieved by: 1.
combining Klf4 with modified reprogramming protocols [11]; 2. altering the structure of Klf4;
and 3. screening libraries containing DNA sequences that contain the required functional
properties of Klf4 (and potentially other pioneer factors).
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